Tackling complex strokes, where blockages occur in both the brain and neck arteries, is tricky. These cases, called tandem lesions, are not well represented in standard stroke treatment studies. This leaves doctors unsure about the best way to handle them, especially when it comes to fixing the neck
Low magnesium levels, or hypomagnesemia, might be a sneaky issue for people on peritoneal dialysis (PD) or a mix of PD and other treatments. This condition could be more common than we think, but we don't have a clear picture of how often it happens or what it means for patients. One big question is
Pfizer's stock took a hit recently, and it's all tied to a serious issue with one of their drugs. A patient in a long-term study for Hympavzi, a treatment for hemophilia, passed away due to severe complications. This news came out in December 2025, and it's got people talking. The patient had hemop
Breast cancer treatment has seen a big change with a new way to deliver drugs. This method uses tiny particles to carry the medicine directly to the tumor. This is a big deal because it makes the treatment work better and causes fewer side effects. The old way of delivering drugs often caused probl
Researchers recently revisited a study on ivermectin's potential in treating mild COVID-19 symptoms. The focus was on a special nasal spray form of the drug. This form is designed to stick to the inside of the nose. The goal was to see if it could help with upper respiratory issues. The study looke
Dr. Michael Pfeffer is a busy man. He is the Chief Information Digital Officer at Stanford Health Care and also works as a doctor and teacher. He loves his job because it lets him see how technology can make healthcare better. He thinks technology is most useful when it helps doctors and patients in
Hospitals often use alarms to alert staff when patients at risk of falling try to move around. But do these alarms actually work? A recent study put them to the test. The study was a randomized clinical trial. This means patients were randomly assigned to either have an alarm or not. The goal was t
Genetic testing is becoming a big deal worldwide. It's like having a superpower to peek into someone's DNA. But why isn't everyone using it? There are good reasons and tough challenges. First, let's talk about the good stuff. Genetic testing can spot diseases early. It can help doctors make better
Jyong Biotech, a biotech company based in Taiwan, has noticed some unusual activity in its stock price and trading volume. This comes just after a lock-up period ended this month. The company is in talks with some investment funds about buying shares, but they say they're not hiding any big news tha
Genenta Science, a company working on new ways to fight cancer, has some news to share. Their CEO, Pierluigi Paracchi, has been buying up shares of the company. Over time, he's picked up 30, 000 American Depositary Shares, or ADSs, through open-market purchases. No sales have been reported, just buy
